Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)
Clinical trial NCT03089658 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03089658
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.